Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid
PublicDownloadable Content
open in viewerInterleukin-6 (IL-6) is a cytokine, which contributes to inflammation and tissue injury in several diseases. Thus, inhibition of IL-6 production may be a useful strategy for treatment of patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). A synthetic nonpsychoactive cannabinoid, ajulemic acid (AjA), prevents joint damage in experimental arthritis. Results presented here indicate that addition of AjA to human monocyte derived macrophages (MDM) in vitro reduced steady state levels of IL-6 mRNA and subsequent secretion of IL-6 from LPS stimulated cells. Although AjA binds to and activates PPAR-gamma, its anti IL-6 effects were PPAR-gamma independent. Evidence from these studies supports the view that AjA may prove to be an effective, safe anti-inflammatory agent.
- This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.
- Creator
- Publisher
- Identifier
- E-project-042407-120642
- Advisor
- Year
- 2007
- Sponsor
- Date created
- 2007-04-24
- Resource type
- Major
- Rights statement
Relations
- In Collection:
Items
Permanent link to this page: https://digital.wpi.edu/show/6h440t94f